Back to results
US 2019/0290689 A1Published application
Anti-ageing pharmaceutical preparation
AssigneeOrthogen AG
InventorsPeter WEHLING, Julio REINECKE
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeOrthogen AG
InventorsPeter WEHLING, Julio REINECKE
Estimating the term…
The present invention provides a pharmaceutical preparation for use by injection into the skin, wherein the pharmaceutical preparation is preparable by a production method comprising the steps of providing a liquid collected from an organism, which liquid comprises cellular constituents of blood, providing a vessel or containment means, said vessel or containment means having an internal surface, and contacting said liquid with said vessel or containment means, wherein (a) said production method further comprises the step of incubating said liquid in said vessel or containment means for an incubation time, and optionally removing cellular constituents of said liquid after said incubation, (b) said liquid comprises exosomes, and said production method further comprises the steps of concentrating said exosomes and optionally removing cellular constituents of said liquid after said concentration, or the step of isolating said exosomes, or (c) said production method further comprises the step of avoiding incubation of said liquid, and the step of removing cellular constituents of said liquid contacted with said vessel or containment means.
A pharmaceutical preparation for use by injection into the skin, wherein the pharmaceutical preparation is preparable by a production method comprising the steps of providing a liquid collected from an organism, which liquid comprises cellular constituents of blood, providing a vessel or containment means, said vessel or containment means having an internal surface, and contacting said liquid with said vessel or containment means, wherein
The pharmaceutical preparation for use according to any of the above claims, wherein the step of removing cellular constituents is a step of removing the erythrocytes, the platelets or the entirety of cellular constituents.
The pharmaceutical preparation for use according to any of the above claims, wherein
The pharmaceutical preparation for use according to any of the above claims, wherein said injection is carried out at a depth of less than 3 mm.
The pharmaceutical preparation for use according any of the above claims, wherein said injection into the skin is an injection into the dermis or subcutis.
The pharmaceutical preparation for use according to any of the above claims, wherein the use involves one or more subsequent injections, and a time interval between consecutive injections is 1 day to 52 weeks.
The pharmaceutical preparation for use according to any of the above claims (1) in the treatment of ageing or (2) as an anti-ageing agent.
The pharmaceutical preparation for use according to any of the above claims, wherein said organism is a human being.
The pharmaceutical preparation for use according to any of the above claims, wherein
The pharmaceutical preparation for use according to any of the above claims, wherein said pharmaceutical preparation comprises exosomes.
The pharmaceutical preparation for use according to any of the above claims, which comprises serum or plasma.
The pharmaceutical preparation for use according to any of the above claims, wherein said incubation is carried out
The pharmaceutical preparation for use according to any of the above claims, wherein said vessel or containment means
The pharmaceutical preparation for use according to any of the above claims, wherein said use is
Dependencies are inferred from the claim text.